Lebwohl M, Blauvelt A, Menter A, Papp K, Jacobson A. Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab. J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 3];3:S26. Available from: https://jofskin.org/33014/index.php/skin/article/view/753